Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update

Insmed (INSM) Misses Q2 EPS by 22c

August 5, 2021 8:12 AM EDT

Insmed (NASDAQ: INSM) reported Q2 EPS of ($1.07), $0.22 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $45.4 million versus the consensus estimate of $43.72 million.

"Insmed made meaningful progress in the second quarter of 2021, with important achievements across our four pillars-ARIKAYCE, brensocatib,... More